期刊文献+

血尿酸水平对老年冠心病心力衰竭患者预后的影响 被引量:7

Influence of serum uric acid on prognosis of elderly patients with chronic heart failure and coronary artery disease
下载PDF
导出
摘要 目的分析老年冠心病心力衰竭患者的血尿酸水平对其预后的影响。方法入选2005年1月至2007年12月老年冠心病合并慢性心力衰竭患者783例。按尿酸水平的四分位间距分为低水平组(195例)、较低水平组(195例)、较高水平组(195例)和高水平组(198例),比较各水平组的病死率。按随访期是否死亡分为死亡组(199例)和生存组(584例),采用多因素Cox回归分析尿酸水平对老年冠心病合并心力衰竭患者预后的影响。结果从低到高水平尿酸组的病死率依次为23.6%、21.0%、15.9%和43.4%,组间比较差异有统计学意义(χ2=44.66,P<0.01)。死亡组患者的年龄[(73.3±8.7)岁比(70.0±9.7)岁,t=-4.24,P=0.000]、尿酸水平[(423.71±189.84)μmol/L比(353.28±122.58)μmol/L,t=-6.014,P=0.000]及合并贫血(24.1%比17.6%,χ2=4.008,P=0.045)、心房颤动(31.2%比17.5%,χ2=16.800,P=0.000)、肾衰竭(34.7%比22.1%,χ2=12.441,P=0.000)的比例均大于生存组,而射血分数(49.43%±12.19%比56.49%±11.14%,t=5.33,P=0.000)、服用血管紧张素转换酶抑制剂/血管紧张素Ⅱ受体拮抗剂的比例(70.9%比78.9%,χ2=5.458,P=0.019)小于生存组。高水平的尿酸(≥437.0μmol/L,HR=1.520,P=0.044)、年龄(HR=1.026,P=0.002)、纽约心脏病协会(NYHA)心功能分级Ⅲ~Ⅳ级(HR=1.300,P=0.006)及心房颤动(HR=1.547,P=0.006)是老年冠心病心力衰竭患者预后不良的独立危险因素。结论血尿酸水平可作为老年冠心病心力衰竭患者心原性死亡的预后指标,其作用独立于影响心力衰竭患者生存的其他因素,具有一定的临床预后判断价值。 Objective To study the influence of serum uric acid (UA) on prognosis of elderly patients with chronic heart failure (CHF) and coronary artery disease (CAD). Methods From January 2005 to December 2007, 783 patients clinically diagnosed with CHF and CAD were enrolled from the cardiology department of 2nd Hospital Tianjin Medical University. Patients were divided into four groups according to serum UA level (quartile). During the mean follow up of 35 months, 199 cases died and 584 survived. Cox regression analysis was used to confirm the associations of uric acid level and prognosis of the patients. Results Mortality was significantly different (P 〈0. 01 ) among the groups. Compared with survived patients, those died were older [ (73.3 ± 8.7 ) years vs. (70. 0 ± 9. 7 ) years, t = - 4. 24, P = 0. 000], had higher serum UA level [ (423.71 _± 189.84) μmol/L vs. (353.28 ± 122. 58) μmol/L, t =- 6. 014, P = 0. 000 ] and had more proportion of anemia (24. 1% vs. 17.6%, X2 = 4. 008, P = 0. 045 ), atrial fibrillation (31.2% vs. 17. 5% , X^2 = 16. 800, P =0. 000) and renal failure (34. 7% vs. 22. 1%, X^2 = 12. 441, P =0. 000), while had lower ejection factor (49.43% ± 12. 19% vs. 56.49% ± 11.14% , t =5.33, P = 0. 000), less using of angiotensin converting enzyme inhibitors (70. 9% vs. 78.9%, X^2= 5.458, P=0. 019 ). Multivariate Cox regression analysis showed that highest serum UA level ( ≥ 437 μmol/L, HR=1.520, P=0.044), age (HR=1.026, P=0.002), NYHA Ⅲ -Ⅳ(HR=1.300, P= 0. 006) and atrial fibrillation ( HR = 1. 547, P = 0. 006 ) were independent predictors of cardiac death. Conclusions Serum UA level is an independent predictor of cardiac death in elderly patients with CHF and CAD.
作者 宋芳 王林
出处 《中国心血管杂志》 2013年第4期249-252,共4页 Chinese Journal of Cardiovascular Medicine
关键词 尿酸 心力衰竭 预后 Uric acid Heart failure Prognosis
  • 相关文献

参考文献7

  • 1Ekundayo OJ,Dell' talia LJ,Sanders PW,et al.Association between hyperuricemia and incident heart failure among older adults:a propensity-matched study.Int J Cardiol,2010,142:279-287.
  • 2Nomenclature and criteria for diagnosis of ischemic heart disease.Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature.Circulation,1979,59:607-609.
  • 3无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3691
  • 4王娓娓,张红苗,张莹,李洁茹.老年高血压患者高尿酸血症与缺血性脑卒中相关性分析[J].中华老年医学杂志,2012,31(6):462-464. 被引量:13
  • 5Strasak AM,Kelleher CC,Brant LJ,et al.Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28613 elderly women:a prospective 21-year follow-up study.Int J Cardiol,2008,125:232-239.
  • 6Tamariz L,Harzand A,Palacio A,et al.Uric acid as a predictor of all-cause mortality in heart failure:a meta-analysis.Congest Heart Fail,2011,17:25-30.
  • 7Hamaquchi S,Furumoto T,Tsuchihashi-Makaya M,et al.Hyperuricemia predicts adverse outcomes in patients with heart failure.Int J Cardiol,2011,151:143-147.

二级参考文献50

  • 1王方正,张澍,黄德嘉,华伟,孙宝贵,沈法荣,吴书林,王建安,方全,吴立群,王景峰,王冬梅,郭涛,陈新,中华医学会心电生理和起搏分会心脏再同步治疗专家工作组.心脏再同步治疗慢性心力衰竭的建议[J].中华心律失常学杂志,2006,10(2):90-102. 被引量:90
  • 2Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
  • 3Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
  • 4Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
  • 5Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
  • 6Arnold JM, Liu P, Demers C, et al. Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006 : diagnosis and management. Can J Cardiol, 2006, 22 (1): 23-45.
  • 7Heart Failure Society of America. HFSA 2006 Comprehensive Heart Failure Practice Guideline. J Card Fail, 2006, 12 ( 1 ) : e1-2.
  • 8Enright PL, Sherrill DL Reference equations for the six-minute walk in healthy adults. Am J Respir Crit Care Med, 1998, 158(5 pt 1) :1384-1387.
  • 9Troosters T, Gosselink R, Decramer M. Six minute walking distance in healthy elderly subjects. Eur Respir J, 1999, 14(2) : 270-274.
  • 10Maisel A. B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? Circulation, 2002, 105 (20):2328-2331.

共引文献3702

同被引文献58

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部